HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Endocrine-Related Cancer
Supplementary Material

Supplementary material related to the following articles is available online:

From the Current Issue: 15 (3); [Table of Contents]

Caroline D E Margetts, Mark Morris, Dewi Astuti, Dean C Gentle, Alberto Cascon, Fiona E McRonald, Daniel Catchpoole, Mercedes Robledo, Hartmut P H Neumann, Farida Latif, and Eamonn R Maher

Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma
ERC 2008; 15(3): 777-786 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Heng Hong Lee, Yansong Zhu, Karthik M Govindasamy, and Ganesan Gopalan

Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells
ERC 2008; 15(3): 765-775 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

From Past Issues:

Lucia Languino, Hira Goel, Sophia Kogan, and Jing Li

Integrins in Prostate Cancer Progression
ERC 2008; 0(2008): ERC-08-0019v1-ERC-08-0019 [Abstract]  

Article supplement(s): [Erratum]

N B Kiss, J Geli, F Lundberg, C Avci, D Velazquez-Fernandez, J Hashemi, G Weber, A Höög, T J Ekström, M Bäckdahl, and C Larsson

Methylation of the p16^INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas
ERC 2008; 15(2): 609-621 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Vera Cappelletti, Manuela Gariboldi, Loris De Cecco, Sara Toffanin, James F Reid, Lara Lusa, Emilio Bajetta, Luigi Celio, Marco Greco, Alessandra Fabbri, Marco A Pierotti, and Maria Grazia Daidone

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer
ERC 2008; 15(2): 439-449 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

H-C Jennifer Shen, Jennifer E Rosen, Lauren M Yang, Sharon A Savage, A Lee Burns, Carmen M Mateo, Sunita K Agarwal, Settara C Chandrasekharappa, Allen M Spiegel, Francis S Collins, Stephen J Marx, and Steven K Libutti

Parathyroid tumor development involves deregulation of homeobox genes
ERC 2008; 15(1): 267-275 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

Eva-Maria Duerr, Yusuke Mizukami, Aylwin Ng, Ramnik J Xavier, Hirotoshi Kikuchi, Vikram Deshpande, Andrew L Warshaw, Jonathan Glickman, Matthew H Kulke, and Daniel C Chung

Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
ERC 2008; 15(1): 243-256 [Abstract] [Full Text]  

Article supplement(s): [Supplemental Data]

S Fontanière, J Tost, A Wierinckx, J Lachuer, J Lu, N Hussein, F Busato, I Gut, Z-Q Wang, and C-X Zhang

Gene expression profiling in insulinomas of Men1 ß-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic ß-cell tumorigenesis
ERC 2006; 13(4): 1223-1236 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

S Tozlu, I Girault, S Vacher, J Vendrell, C Andrieu, F Spyratos, P Cohen, R Lidereau, and I Bieche

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
ERC 2006; 13(4): 1109-1120 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Data]

S Rinaldi, P H M Peeters, F Berrino, L Dossus, C Biessy, A Olsen, A Tjonneland, K Overvad, F Clavel-Chapelon, M C Boutron-Ruault, B Téhard, G Nagel, J Linseisen, H Boeing, P H Lahmann, A Trichopoulou, D Trichopoulos, M Koliva, D Palli, S Panico, R Tumino, C Sacerdote, C H van Gils, P van Noord, D E Grobbee, H B Bueno-de-Mesquita, C A Gonzalez, A Agudo, M D Chirlaque, A Barricarte, N Larrañaga, J R Quiros, S Bingham, K T Khaw, T Key, N E Allen, A Lukanova, N Slimani, R Saracci, E Riboli, and R Kaaks

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
ERC 2006; 13(2): 593-605 [Abstract] [Full Text]  

Article supplement(s): [Link to related commentary]

Eva S Schernhammer, Jeff M Holly, David J Hunter, Michael N Pollak, and Susan E Hankinson

Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II
ERC 2006; 13(2): 583-592 [Abstract] [Full Text]  

Article supplement(s): [Link to related commentary]

G Capurso, S Lattimore, T Crnogorac-Jurcevic, F Panzuto, M Milione, V Bhakta, N Campanini, S M Swift, C Bordi, G Delle Fave, and N R Lemoine

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets
ERC 2006; 13(2): 541-558 [Abstract] [Full Text]  

Article supplement(s): [Supplementary Table]

Andrew G Renehan, Michelle Harvie, and Anthony Howell

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on
ERC 2006; 13(2): 273-278 [Abstract] [Full Text]  

Article supplement(s): [Link to related articles]

Adriano Angelucci, Giovanni Luca Gravina, Nadia Rucci, Danilo Millimaggi, Claudio Festuccia, Paola Muzi, Anna Teti, Carlo Vicentini, and Mauro Bologna

Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
ERC 2006; 13(1): 197-210 [Abstract] [Full Text]  

Article supplement(s): [Link to Commentary]

Nicola Normanno and William J Gullick

Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
ERC 2006; 13(1): 3-6 [Abstract] [Full Text]  

Article supplement(s): [Link to related article]